186) Findings are discussed in light of other s |
187) Findings are discussed in relation to the |
188) Main findings are as follows: (a) level of stat |
189) However, these findings are based on group comparisons, a |
190) These findings are consistent with dilution-indu |
191) The findings are consistent with epidemiologic |
192) These paradoxical findings are consistent with the theory th |
193) These findings are corroborated by an analysis o |
194) These findings are discussed in the light of cur |
195) These findings are discussed in the perspective |
196) These findings are discussed via the Modifier Mo |
197) Practical implications for the current findings are discussed. |
198) The implications of these findings are discussed. |
199) and pathophysiological relevance of these findings are discussed. |
200) available data from published studies and findings are equivocal about the efficacy |
201) The findings are instructive that prevailing a |
202) Biologically important findings are reported, and these findings |
203) Findings support ARSAA-II A & E to ass |
204) Findings support the enduring nature of pe |
205) Findings support the importance of early d |
206) These findings support a function of OPN in medi |
207) The findings support multi-modal hand hygiene |
208) Together, our findings support that MeCP2 regulates a un |
209) Our findings support the assumption that recip |
210) These findings support the hypothesis that hallu |
211) The neuropsychological findings support the hypothesis that these |
212) Our findings support the idea that the PTGI-C- |
213) Our findings support the inclusion of self- an |
214) The findings support the notion that early-ons |
215) sociated with cortisol secretion, and our findings support the perseverative cogniti |
216) Together, our findings support the premise that variatio |
217) These findings support the viability of ibudilas |
218) These findings support the view that tDCS intera |
|